US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Class II · Moderate risk Terminated

Ropivacaine HCl 0.25% in 0.9% Sodium Chloride

Reason Lack of Assurance of Sterility - the firm is recalling select sterile drug products.

Cantrell Drug Company NDC 52533-185-75 D-0203-2017
Class II · Moderate risk Terminated

Rocuronium Bromide 50 mg/5 mL Injection Solution

Reason Lack of Assurance of Sterility - the firm is recalling select sterile drug products.

Cantrell Drug Company NDC 52533-064-15 D-0202-2017
Class II · Moderate risk Terminated

Morphine Sulfate 1 mg/mL in 0.9% Sodium Chloride

Reason Lack of Assurance of Sterility - the firm is recalling select sterile drug products.

Cantrell Drug Company NDC 52533-160-75 D-0199-2017
Class II · Moderate risk Terminated

Lidocaine HCl 1%

Reason Lack of Assurance of Sterility - the firm is recalling select sterile drug products.

Cantrell Drug Company D-0197-2017
Class II · Moderate risk Terminated

Heparin Sodium 5

Reason Lack of Assurance of Sterility - the firm is recalling select sterile drug products.

Cantrell Drug Company NDC 52533-097-24 D-0193-2017
Class II · Moderate risk Terminated

Heparin Sodium

Reason Lack of Assurance of Sterility - the firm is recalling select sterile drug products.

Cantrell Drug Company NDC 52533-148-16 D-0192-2017
Class II · Moderate risk Terminated

Glycopyrrolate 1 mg/5 mL

Reason Lack of Assurance of Sterility - the firm is recalling select sterile drug products.

Cantrell Drug Company NDC 52533-028-15 D-0191-2017
Class II · Moderate risk Terminated

Fentanyl Citrate 2

Reason Lack of Assurance of Sterility - the firm is recalling select sterile drug products.

Cantrell Drug Company NDC 52533-024-61 D-0189-2017
Class II · Moderate risk Terminated

Fentanyl Citrate 1

Reason Lack of Assurance of Sterility - the firm is recalling select sterile drug products.

Cantrell Drug Company NDC 52533-024-35 D-0188-2017
Class II · Moderate risk Terminated

Calcium Chloride

Reason Lack of Assurance of Sterility - the firm is recalling select sterile drug products.

Cantrell Drug Company D-0187-2017
Class II · Moderate risk Terminated

Calcium Chloride

Reason Lack of Assurance of Sterility - the firm is recalling select sterile drug products.

Cantrell Drug Company NDC 52533-102-09 D-0186-2017
Class II · Moderate risk Terminated

Phenylephrine HCl 1 mg/10 mL

Reason Lack of Assurance of Sterility - the firm is recalling select sterile drug products.

Cantrell Drug Company NDC 52533-171-12 D-0185-2017
Class II · Moderate risk Terminated

Calcium Chloride 1 g/50 mL* Added to 5% Dextrose

Reason Lack of Assurance of Sterility - the firm is recalling select sterile drug products.

Cantrell Drug Company NDC 52533-175-37 D-0184-2017
Class II · Moderate risk Terminated

Desoximetasone Ointment USP

Reason Failed Stability Specifications; out-of specification value for homogeneity / phase separation.

Akorn Inc NDC 61748-206-15 D-0152-2017
Class II · Moderate risk Terminated

Lactulose Solution

Reason Microbial Contamination of Non-Sterile Products: bulk solution tested positive for the presence of the bacteria, Burkholderia cepacia.

VistaPharm, Inc. NDC 66689-039-01 D-0146-2017
Class II · Moderate risk Terminated

L-Cysteine Hydrochloride Injection

Reason Lack of Assurance of Sterility: a recent FDA inspection at the manufacturing firm raised concerns that the product sterility may be compromised.

Sandoz Inc NDC 66758-005-01 D-0141-2017
Class II · Moderate risk Terminated

L-Cysteine Hydrochloride Injection

Reason Lack of Assurance of Sterility: a recent FDA inspection at the manufacturing firm raised concerns that the product sterility may be compromised.

Sandoz Inc NDC 66758-004-01 D-0140-2017